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Abstract
Aim To examine whether diabetes-specific emotional distress was related to follow-up glycaemic control in adults with
Type 1 diabetes mellitus.
Methods Adults with Type 1 diabetes mellitus completed the Diabetes Distress Scale and reported sociodemographic
information when attending a clinical consultation at a university endocrinology unit. Blood samples to determine
baseline HbA1c were taken during consultations. All respondents’ HbA1c measurements registered from January 2009 to
December 2011 were collected from medical records. The relationship between baseline diabetes-specific emotional
distress and HbA1c was examined with linear mixed-effects models in 175 patients with complete data.
Results After controlling for confounders, baseline diabetes-specific emotional distress and glycaemic control were
significantly associated (fixed-effect coefficient 0.40, P < 0.001) and the regimen-related distress subscale had the
strongest association with glycaemic control (fixed-effect coefficient 0.47, P < 0.001). The two-item measure of
diabetes-specific distress had a weaker but still significant association with glycaemic control (fixed-effect coefficient
0.31, P < 0.001). None of these relationships was significant after adjusting for the baseline HbA1c.
Conclusions People with elevated baseline diabetes-specific emotional distress are at risk of prolonged suboptimum
glycaemic control; therefore, elevated diabetes-specific emotional distress, especially regimen-related distress, might be
an important marker for prolonged suboptimum glycaemic control, and might indicate a need for special attention
regarding patient self-management.
Diabet. Med. 32, 1304–1310 (2015)
Introduction
Diabetes-specific emotional distress can be defined as the
experience of emotional problems related to living with
diabetes and its treatment [1,2]. People with diabetes mellitus
face considerable demands in maintaining a healthy lifestyle
and adhering to the treatment regimen in the context of
family, social environment and the healthcare system
[1–3]. Diabetes-specific emotional distress is seen to be
associated with poor glycaemic control in people with Type 1
diabetes mellitus [4,5]. To date, most studies investigating
the relationship between diabetes-specific emotional distress
and glycaemic control have used either a cross-sectional
methodology [4–7] and/or have studied samples of people
with Type 2 diabetes mellitus [2,3,8–12]. A recent systematic
review of diabetes self-care highlights the lack of longitudinal
studies investigating the association between physical and
emotional health in order to improve interventions in
diabetes care [13]. In cross-sectional analyses of adults with
Type 1 diabetes, depression, anxiety and overall well-being
were not significantly related to glycaemic control, whereas
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diabetes-specific emotional distress was significantly associ-
ated with glycaemic control [5]. Better understanding of the
longitudinal relationship between diabetes-specific emotional
distress and glycaemic control could contribute important
knowledge for use in clinical consultations. The aim of the
present study, therefore, was to examine whether diabetes-
specific emotional distress is related to subsequent glycaemic
control in adults with Type 1 diabetes mellitus.
Patients and methods
Patients and setting
A total of 319 people aged 18–69 years with Type 1 diabetes,
attending an outpatient endocrinology unit at a university
hospital in Norway between October 2008 and the end of
January 2009, were invited to participate in this study, and
235 (74%) agreed to participate. The patients completed
self-reported questionnaires either at the outpatient clinic or
at home, in addition to providing sociodemographic and
clinical information (Table 1). The study was approved by
the Western Norway Committee for Medical and Health
Research Ethics (19580/865).
Measures
Follow-up HbA1c was handled as a continuous variable, and
constituted the dependent variable in all analyses. The
baseline HbA1c of each patient was measured during the
initial clinical consultation at which consent was obtained,
and follow-up HbA1c values, obtained from clinical consul-
tations between January 2009 and December 2011, were
recorded from the patients’ medical records. The date each
patient was invited to participate was registered as the
baseline date, and the time variable for each HbA1c
measurement was calculated as months from baseline.
The Diabetes Distress Scale (DDS) was used to assess the
baseline level of diabetes-specific emotional distress. The
questionnaire consists of 17 items with a six-point Likert
scale [1], and includes four subscales: regimen-related
distress (five items); emotional burden (five items); interper-
sonal-related distress (three items); and physician-related
distress (four items). The DDS has shown good reliability
Table 1 Baseline descriptive information of 175 respondents included
and 60 respondents excluded in the linear mixed-effect models
(a) Included
respondents*
(b) Excluded
respondents* P
Mean (SD) age†, years 39.4 (13.5) 37.6 (14.1) 0.356
Men, n (%) 97 (55) 38 (63) 0.295
Mean duration†,
years
19.0 (11.7) 17.6 (12.8) 0.437
Mean baseline
HbA1c, mmol/mol
[HbA1c% (SD)]
67 [8.3 (1.7)] 61 [7.7 (1.2)] 0.011
Presence of one or
more late
complications:
yes, n (%)‡
73 (42) 8 (31) 0.392
Education‡, n (%) 0.560
> 4 years higher
education
21 (12) 9 (17.0)
≤ 4 years higher
education
50 (29) 17 (32.1)
High school 81 (46) 23 (43.4)
Primary school
(9 years)
23 (13) 4 (7.5)
Living with a partner:
yes, n (%)‡
112 (64) 34 (58.6) 0.531
Insulin regimen, n (%)‡ 0.110
1–3 insulin injections
per day
13 (7.5) 9 (15.3)
Multi-injections 117 (67.2) 32 (54.2)
Insulin pump 44 (25.3) 18 (30.5)
Mean (SD) DDS total
score§,¶
2.0 (0.8) 2.0 (0.8) 0.996
DDS emotional
burden§,¶
2.3 (1.1) 2.3 (1.1) 0.854
DDS regimen-related
distress§,¶
2.2 (1.1) 2.1 (1.0) 0.694
DDS interpersonal-
related distress§,¶
1.7 (0.9) 1.6 (0.8) 0.674
DDS physician-related
distress§,¶
1.5 (0.7) 1.6 (1.0) 0.464
DDS2§,¶ 2.3 (1.2) 2.2 (1.1) 0.637
DDS, Diabetes Distress Scale; DDS2, two-item Diabetes
Distress scale.
*175 respondents included and 60 respondents excluded from
the linear mixed-effect models as a consequence of complete
case analyses.
†Age and duration at baseline date
‡Number of cases in column (b) for late complications: 26;
education: 53; living with a partner: 58. Insulin regimen not
included in analyses models, n = 174 in column (a) and n = 59
in column (b).
§1–6 scales: the DDS, the emotional burden subscale, the
regimen-related distress subscale, the interpersonal-related dis-
tress subscale, the physician-related distress subscale, and the
DDS2.
¶Cronbach’s a, n = 235/ n = 175: DDS total: 0.917/0.919,
emotional burden subscale: 0.877/0.880, regimen-related dis-
tress subscale: 0.841/0.848, interpersonal-related distress sub-
scale: 0.811/0.829, physician-related distress subscale: 0.829/
0.782, DDS2: 0.706/0.722.
What’s new?
• In adults with Type 1 diabetes, elevated baseline
diabetes-specific emotional distress is associated with
worse glycaemic control over a 1–3-year period and
regimen-related distress had the strongest association
with subsequent glycaemic control.
• Baseline diabetes-specific emotional distress is associ-
ated with the stable component of glycaemic control
and does not account for within-individual change in
glycaemic control over 1–3 years.
• Elevated diabetes-specific emotional distress may be an
important marker for risk of prolonged suboptimum
glycaemic control.
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and validity across cultures in Type 1 diabetes [1,4,14]. A
validated Norwegian version was used [14]. The two-item
measure of diabetes-specific distress, the DDS2, proposed by
Fisher et al. [15] was used in parallel analyses. The DDS2
consists of the following items: ‘feeling overwhelmed by the
demands of living with diabetes’, and ‘feeling that I am often
failing with my diabetes regimen’. Scores ranging from 1 to 6
(highest possible distress level) were calculated for the DDS
total score, each of the four DDS subscales and the DDS2.
The means of valid items were used if ≥ 50% of the items
had valid responses. If > 50% of items were missing, the scale
score is missing. DDS scores were also dichotomized
into ≥ 3.0 for severe distress, based on the high distress
group of the three distress categories found in Fisher et al. [9].
Data analyses
Histograms and descriptive information from the diabetes
distress scales were inspected to examine the distribution.
Those with missing values on any analytical variable were
excluded from analyses (60 respondents, 26%), resulting in a
sample of 175 patients for the primary analyses (Fig. 1).
Attrition analyses were performed using independent
t-tests and exact chi-squared tests to compare: (a) respon-
dents (n = 235) with non-respondents (n = 84); (b) the 21
cases that were excluded because no follow-up HbA1c
registrations were available with the remaining 214 cases;
(c) the 175 cases included in the linear mixed-effect models
with the 60 excluded cases.
The follow-up course of HbA1c (every follow-up HbA1c
counted individually) was assessed according to the propor-
tion of patients who had a > 0.3-unit (HbA1c %) change in
either direction from baseline to the last follow-up in glycae-
mic control; also assessed were the proportions that had
neither a 0.3-unit (HbA1c %) increase nor decrease and the
proportion that had both. There is no widely accepted,
empirically established value of clinically meaningful
difference in HbA1c; however, the difference that is accepted
as evidence of non-inferiority is 0.3 units (HbA1c%) [16]. This
corresponds to a difference of ~ 0.2 standard deviations of
the baseline HbA1c in the present study, a difference that
corresponds to the upper limit of a ‘small’ effect size [17].
The primary analyses used linear mixed-effect models to
examine whether baseline level of diabetes-specific emotional
distress was associated with glycaemic control during
subsequent follow-up. A total of 652 follow-up HbA1c
observations was included in the primary analyses (mean
number of observations per case 5.45, range 1–16). Follow-
up HbA1c constituted the dependent variable in the linear
mixed-effect models, and these were clustered within patient.
Baseline HbA1c was not included in the dependent variable.
Four sets of analyses were conducted with 1) the DDS
total score, 2) the four DDS subscales, 3) the DDS2 and 4) the
binary threshold (DDS ≥ 3) for severe distress as explanatory
319  
26 paents declined to parcipate and 58 
paents did not return quesonnaires 
 
37 paents had missing data on 1 
explanatory variable 
n = 235 
10 had had no consultaon with an 
HbA1c registraon during the follow-
up period 
11 were not possible to idenfy in 
medical records 
21 excluded: 
No follow-up HbA1c registraons available 
 
 
 
n = 214 
n = 175 Late complicaons and 
educaon 
1: Partnership status 31: Late 
complicaons 
5: Educaon 
1 paent had missing data on 2 
explanatory variables 
1 paent had missing data on 3 
explanatory variables 
39 paents registered as missing in linear mixed-eﬀect models 
because of missing in explanatory variable/s 
Late complicaons, educaon and 
partnership status 
FIGURE 1 Flow chart of attrition from the 319 patients invited to the 175 patients included in the linear mixed-effect models.
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variables. In analyses of the DDS subscales, separate models
were performed for each subscale. Fisher et al. [15] showed
that items from the regimen-related distress and the emotional
burden subscales seem to capture most of the distress that the
DDS was assessing; therefore, a model containing these two
subscales was also estimated. The first model in each set of
analyses adjusted for potential confounders (age, gender,
education, late complications, and partnership status; these
potential confounders were not of primary interest in this
study, and are therefore not presented in the Tables). The
second model in each set of analyses also adjusted for time to
follow-up HbA1c measurement and baseline HbA1c. Random
effects included intercept and time slope in all models adjusted
for time, otherwise random intercept only was used.
Multiple imputation with 150 imputed datasets was used
[18] to examine whether the results from the complete case
analyses were replicated on the models for DDS total score,
for the combination of regimen-related distress and emo-
tional burden subscales, and for the DDS2. The imputation
models, clustered on the 214 patients (because of missing
data on the dependent variable for 21 cases), included time
from baseline, HbA1c, baseline HbA1c, DDS, age, gender,
living alone, late complications, education, DDS scales in
each analysis model, and a uniform random draw (because a
level one variable had to be included for technical reasons).
Burn-in was 5000 Gibbs sampling iterations, and the number
of iterations between each imputed dataset was 1000.
The R (The R Foundation for Statistical Computing,
Vienna, Austria) package NLME was used for mixed effects
models, REALCOM IMPUTE [19] was used for multiple imputa-
tion, and SPSS 21/22 (IBM Corp., Armonk, NY, USA) was
used for other analyses.
Results
The attrition analyses showed that there were: (a) no
significant differences between the 235 respondents and the
84 non-respondents in mean age (39 vs. 38 years;
P = 0.535), gender (57 vs. 66% men; P = 0.244), or baseline
HbA1c [65 vs. 68 mmol/mol (HbA1c 8.1 vs. 8.4%);
P = 0.285]; (b) no significant differences between the 21
excluded cases because no follow-up HbA1c registrations
were available and the 214 remaining cases in the examined
variables (HbA1c, age, duration, DDS total score, DDS
subscales, DDS2, gender, late complications, partnership
status; all P values ≥ 0.211); (c) no significant differences in
the tested variables between the 175 included respondents
and the 60 respondents excluded from the linear mixed-effect
models (Table 1), except for a significant difference between
the two groups in baseline HbA1c [67 vs. 61 mmol/mol
(HbA1c 8.3 vs. 7.7%); P = 0.011], indicating that the
excluded cases had significantly better glycaemic control
than those included in the linear mixed-effect models.
Descriptive analyses of proportion of patients that had a
change of > 0.3 units (HbA1c %) from the baseline value
during the follow-up course showed that 98 patients (46%)
had an increase of > 0.3 units, 66 patients (31%) had a
decrease of > 0.3 units, 27 patients (13%) did not have
either an increase or decrease of > 0.3 units (i.e. had stable
glycaemic control within the limit of 0.3 units change from
baseline), and 23 patients (11%) had both an increase and a
decrease of > 0.3 units during follow-up (total does not
sum to 100% because of rounding). Note that 24 patients
only had one follow-up measurement, and it was not
possible for them to have both an increase and a decrease in
this analysis.
Results from the main analyses are shown in Table 2. In
the first set of analyses (including DDS total score), the first
model (not adjusted for time and baseline HbA1c) showed
that diabetes-specific emotional distress was significantly
related to follow-up glycaemic control (fixed-effect coeffi-
cient 0.40, P < 0.001). In the second model (adjusted for
time and baseline HbA1c) diabetes-specific emotional distress
was not significant (P = 0.314).
In the second set of analyses (the DDS subscales), the
results were as follows. The separate analyses of each DDS
subscale, adjusted for potential confounders (but not time
and baseline HbA1c), showed that glycaemic control was
significantly related to the regimen-related distress (fixed-
effect coefficient 0.47, P < 0.001) and emotional burden
subscales (fixed-effect coefficient 0.17, P = 0.023), but not
the interpersonal-related distress or physician-related dis-
tress subscales (P = 0.359 and 0.125, respectively). When
examining the regimen-related distress and the emotional
burden subscales together (data not shown), both were
significant (P < 0.001 and P = 0.009, respectively); while
the regimen-related distress subscale still had a positive
relationship (fixed-effect coefficient 0.64) with glycaemic
control, the coefficient for the emotional burden subscale
changed to negative (fixed-effect coefficient -0.24), possibly
as a result of multicollinearity. The second model (regi-
men-related distress and emotional burden subscales
adjusting also for time and baseline HbA1c) showed no
significant relationship for either measure of distress (both
P ≥ 0.309).
In the third set of analyses (the DDS2), a significant
relationship was apparent with glycaemic control (fixed-
effect coefficient 0.31, P < 0.001), but not when controlling
for time and baseline HbA1c (P = 0.140). The fourth set of
analyses (threshold for distress ≥ 3) followed the similar
pattern, where diabetes-specific emotional distress was
significantly related to follow-up HbA1c (distress ≥ 3:
fixed-effect coefficient 1.01, P < 0.001), but not when
adjusting for baseline HbA1c and time (P = 0.228).
Baseline HbA1c was significantly related to follow-up
glycaemic control (fixed-effect coefficients 0.43–0.45, all
P values < 0.001) in models adjusted for baseline HbA1c
(Table 2). Of the covariates, educational level and having
late complications were significantly related to follow-up
glycaemic control in models not adjusted for HbA1c baseline
ª 2015 The Authors.
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and time, and education remained significant when adjusting
for the baseline HbA1c and time in all models.
Results from the multiple imputation analyses were
consistent with the results from the complete case analyses.
Estimates were generally close to the estimates calculated by
complete case analyses, but a few coefficients differed
notably; the largest difference was for DDS total score,
where the coefficient decreased from 0.40 in complete case
analysis to 0.35 in multiple imputation. The standard errors
were generally somewhat smaller.
Discussion
Elevation of diabetes-specific emotional distress was signif-
icantly associated with follow-up HbA1c when the baseline
level of glycaemic control was not controlled for, and the
regimen-related component of distress showed the strongest
relationship with follow-up HbA1c. The baseline value of
HbA1c was related to follow-up glycaemic control, and no
measure of diabetes-specific emotional distress was signifi-
cantly associated with follow-up glycaemic control when
adjusting for baseline HbA1c. These results parallel those of
Aikens et al. [20] who showed that, in people with Type 2
diabetes, the relationship between depression and glycaemic
control became insignificant when adjusting for baseline
HbA1c.
It is argued that HbA1c levels are stable over time [21], and
deVries et al. [22] concluded that persistent poor glycaemic
control is a common and serious problem in Type 1 diabetes
mellitus. Descriptive analyses in the present study showed
that only 13% sustained within the limits of 0.3 HbA1c units
change of increase or decrease from the baseline value. The
fact that 46% had a > 0.3-unit increase and 31% had
a > 0.3-unit decrease during the follow-up indicates that
there is some variability in the within-patient glycaemic
trajectory; however, this variability was mainly in one of the
directions, as only 11% of patients experienced both an
increase and a decrease during follow-up.
Peyrot et al. [23] argued that glycaemic control consists of
stable and labile components: an individual’s mean level
over time (stable component), and within-person variability
over time (labile component), which might be one explana-
tion of why the association between diabetes-specific emo-
tional distress and glycaemic control became insignificant
when adjusted according to the baseline HbA1c and time.
An increasing number of studies have found that baseline
diabetes-specific emotional distress is associated with base-
line glycaemic control [2,4,5,12], but neither Fisher et al. [2]
Table 2 Diabetes-specific emotional distress [Diabetes Distress Scale (DDS) total score, DDS subscales, DDS2 and DDS non-severe vs. severe
distress] as explanatory variables of follow-up glycaemic control in adults with Type 1 diabetes
Explanatory variables
Not adjusted for time and baseline HbA1c*
,† Adjusted for time and baseline HbA1c*
,†
Coefficient‡ CI P Coefficient‡ CI P
Diabetes-specific distress total score§ 0.40 0.19 to 0.60 <0.001 0.09 0.08 to 0.26 0.314
Months from baseline¶ – – – 0.02 0.05 to 0.01 0.182
Baseline HbA1c – – – 0.45 0.37 to 0.53 <0.001
Each DDS subscale in separate analysis: The DDS subscales together:
Regimen-related distress§,** 0.47 0.33 to 0.61 <0.001 0.10 0.10 to 0.30 0.309
Emotional burden§,** 0.17 0.02 to 0.32 0.023 0.02 0.18 to 0.14 0.829
Interpersonal-related distress§,** 0.09 0.10 to 0.27 0.359 – – –
Physician-related distress§,** 0.18 0.05 to 0.42 0.125 – – –
Months from baseline¶ – – – 0.02 0.05 to 0.01 0.176
Baseline HbA1c – – – 0.43 0.33 to 0.52 <0.001
DDS2§,** 0.31 0.17 to 0.44 <0.001 0.09 0.03 to 0.20 0.140
Months from baseline¶ – – – 0.02 0.05 to 0.01 0.180
Baseline HbA1c – – – 0.44 0.36 to 0.52 <0.001
Diabetes-specific distress ≥ 3** 1.01 0.48 to 1.55 <0.001 0.27 0.17 to 0.71 0.228
Months from baseline¶ – – – 0.02 0.05 to 0.01 0.196
Baseline HbA1c – – – 0.45 0.37 to 0.53 <0.001
DDS, Diabetes Distress Scale; DDS2, two-item Diabetes Distress scale.
*652 HbA1c observations clustered in 175 respondents.
†Controlled also for age, gender, education, late complications, and partnership status (coefficients not shown).
‡Fixed-effect coefficients.
§Scored on 1–6 scale.
¶Coefficients and CIs per 3 months’ change.
**Regimen-related distress subscale, emotional burden subscale, interpersonal-related distress subscale, physician-related distress subscale,
DDS2, and threshold for severe distress at ≥ 3.
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nor Hessler et al. [12] found a prospective relationship
between baseline diabetes-specific emotional distress and
follow-up HbA1c in adults with Type 2 diabetes, a result
replicated in the present study for adults with Type 1
diabetes. More importantly, using time-varying analysis,
Hessler et al. [12] found that a decrease in regimen-related
distress was significantly associated with a decrease in
HbA1c in terms of within-person change, even though mean
aggregate follow-up HbA1c was not significantly different
from baseline. The present results are consistent with an
interpretation that baseline diabetes-specific emotional dis-
tress (including the regimen-related component) is related to
the stable component of glycaemic control, not the labile
component (i.e. within-patient variability in the glycaemic
trajectory), and possibly conversely, within-patient variabil-
ity in the glycaemic trajectory is related to within-patient
variability in diabetes-specific emotional distress (i.e. the
labile component of distress); however, to test this interpre-
tation in Type 1 diabetes would require follow-up measures
of diabetes-specific emotional distress and glycaemic
control.
Fisher et al. [15] proposed that the DDS2 is suitable for an
initial screening of high diabetes-specific emotional distress
in clinical consultations, and showed that DDS2 was
significantly associated with HbA1c levels. The DDS2 con-
sists of items from the regimen-related distress and emotional
burden subscales [15] and a recent study found that items of
regimen-related distress and emotional burden loaded on the
same factor [24]. In the present study the DDS2 showed a
significant relationship with follow-up HbA1c, but not when
adjusting for baseline glycaemic control.
The present study has some limitations. Although the
response rate was 74%, the study included a rather limited
number of patients, partly because 26% of volunteers were
excluded from the analyses as a result of missing values for
variables used in the main analyses. There were few
significant differences, however, in baseline variables
between the included and excluded respondents, and there
were no significant differences in relevant variables between
the cases excluded from the longitudinal data (n = 21) and
the remaining cases (n = 214). In addition, replication of the
complete case analyses by multiple imputation showed
mostly the same pattern. Furthermore, the diabetes distress
scales were found to be right-skewed. We did not have
information about changes in prescribed treatment regimen
during the follow-up period, which could have biased the
results. Also the lack of follow-up data on diabetes-specific
emotional distress precluded time-varying analyses to exam-
ine the association of changes in distress with changes in
glycaemic control. To gain insight into the causal dynamics
of diabetes-specific emotional distress and glycaemic control
we would recommend cohort studies in newly diagnosed
people with Type 1 diabetes.
The present study highlights that diabetes-specific
emotional distress might be a marker for risk of poor
glycaemic control. Our data do not allow us to say whether
relieving this distress will affect glycaemic control, but
suggest that diabetes-specific emotional distress can be used
to identify high-risk patients for more intensive intervention.
A recent study investigating the use of the DDS2 to facilitate
conversation about psychological concerns in clinical con-
sultation, found that a dialogue tool might make it easier to
address psychological issues, but emphasized the importance
of a short tool and the importance of using the tool in a
flexible manner in clinical consultations [25]. Ease of use
favours the two-item DDS2 over the full 17-item DDS, but
the DDS2 does not have as strong a relationship with
glycaemic control as the longer version; however, the five-
item regimen distress scale is shorter than the full DDS, and
has a stronger association with follow-up glycaemic control.
As people with Type 1 diabetes do not have the ability to
produce insulin, variations in regimen adherence can have
major consequences for glycaemic control [23]. Perhaps high
levels of distress related to the diabetes treatment reflect
problems with the regimen [26], which could hinder the
ability to implement the behaviours needed to manage the
demands of the disease and achieve good glycaemic control.
As regimen-related distress accounts for most of the
relationship between diabetes-specific emotional distress
and glycaemic control, it might be the best measure of
distress to identify people at risk of prolonged poor
glycaemic control.
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